Abstract
Background The detailed assessment of fetal brain maturation and development involves morphological evaluation, gyration analysis, and reliable biometric measurements. Manual measurements on conventional 2-D magnetic resonance imaging (MRI) are affected by fetal motion and there is no clear consensus regarding definitions for brain biometric parameters and anatomical landmark placements, making consistent reference plane and slice selection challenging. Automated biometry with 3-D slice-to-volume reconstruction (SVR) has the potential to improve the reliability of derived measurements, allowing precise quantification of fetal brain development. Previous published works have primarily focused on the technical feasibility of automated fetal brain biometry methods for T2-weighted (T2W) MRI. However, none have proposed solutions for automating the reporting of biometry results, which could enhance clinical utility and support real-time integration into routine clinical workflows. Furthermore, there is no consensus on a universal fetal biometry protocol for 3D fetal MRI.
Aim To formalise biometry protocol for 3-D SVR T2W fetal brain MRI and to develop and validate a fully automated biometry reporting pipeline.
Materials and methods Automated extraction of 13 routinely reported linear fetal biometry measurements using deep learning localisation of anatomical landmarks in 3-D reconstructed T2W brain images and presentation of the results in .html report with centile calculation. The automated biometry method was tested on 90 retrospective cases and the fully automated, end-to-end biometry reporting pipeline was prospectively evaluated on 111 cases across a wide range of gestational ages, field strengths and scanning parameters. We also generated normal centile ranges for 19 - 40 weaks GA range from 406 normal control datasets.
Results The retrospective evaluation showed excellent to good localisation for the majority of cases, with the maximum absolute difference between automated vs. manual measurement within 1-3mm range. For the prospective evaluation, more than 98% of all landmark placement were graded as acceptable for interpretation and measurements. The processing time of the pipeline was less than five minutes per case, with the measurements and centiles available at the time of reporting. Inspection of the automated landmark placement and computed biometrics took 1-3 minutes per case. The generated normative growth charts demonstrate high correlation with the trends in the previously reported works.
Conclusion Our approach is the first to develop a pipeline which integrates automated fetal brain biometric measurements, centile calculations and normative growth charts into the clinical workflow, allowing fully automated biometry reporting for T2-weighted motion-corrected SVR MRI.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the MRC grant MR/X010007/1, the NIHR Advanced Fellowship to L.S. NIHR3016640, the Wellcome Trust, Sir Henry Wellcome Fellowship to J.H. 201374/Z/16/Z, the UKRI FLF to J.H. MR/T018119/1, DFG Heisenberg 502024488 the High Tech Agenda Bavaria to J.H., the MRC grant MR/W019469/1, the Wellcome/EPSRC Centre WT203148/Z/16/Z, the NIHR Clinical Research Facility (CRF) at Guys and St Thomas and by the National Institute for Health Research Biomedical Research Centre based at Guys and St Thomas NHS Foundation Trust and Kings College London.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The following relevant datasets were given research ethics committee (REC) approval by the Health Research Authority: "Placental Imaging Project" (REC 16/LO/1573), "Individualised Risk prediction of adverse neonatal outcome in pregnancies that deliver preterm using advanced MRI techniques and machine learning" (REC 21/SS/0082), "CARP" (REC 19/LO/0852), "MEERKAT" (REC 21/LO/0742), "MiBirth" (REC 23/LO/0685), "NANO" (REC 22/YH/0210), and "Quantification of fetal growth and development with MRI" (REC 07/H0707/105). All studies were performed in accordance with relevant ethical guidelines and regulations. Informed written consent was obtained from all participants.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Contributing authors: alena.uus{at}kcl.ac.uk;
Data availability
The individual fetal MRI datasets used for this study are not publicly available due to ethics regulations. For more information please contact Jana Hutter jana.hutter{at}kcl.ac.uk.
